Walvax Biotechnology Co., Ltd.

Quick facts

Marketed products

• Sanofi Pasteur Menactra® vaccine · Immunology / Infectious Disease
  Menactra is a conjugate vaccine that stimulates the immune system to produce antibodies against meningococcal serogroups A, C, W, and Y by presenting polysaccharide antigens linked to a carrier protein.
• Yuxi Walvax MPV ACYW® vaccine

Phase 3 pipeline

• Pfizer PCV13 · Immunology / Infectious Disease
  PCV13 is a pneumococcal conjugate vaccine that stimulates the immune system to produce antibodies against 13 serotypes of Streptococcus pneumoniae.
• vaccination PNEUMOVAX 23 · Immunology / Infectious Disease
  PNEUMOVAX 23 is a polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.
• vaccination PPV23
• Walvax PCV13-TT · Infectious Disease
  Walvax PCV13-TT is a conjugate vaccine that stimulates the body's immune response to protect against pneumococcal disease.

Phase 1 pipeline

• RQ3013

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Walvax Biotechnology Co., Ltd. portfolio CI brief
• Walvax Biotechnology Co., Ltd. pipeline updates RSS